BioCentury
ARTICLE | Company News

ParAllele, Merck SNP deal

May 12, 2004 7:00 AM UTC

ParAllele (South San Francisco, Calif.) will use its SNP discovery and genotyping technology to discover and characterize common and rare genetic variations in selected gene targets from MRK. Under a ...